Position in OTLK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$75,048
New position
Shares Held
47,200
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 68 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Royal Fund Management, LLC holds $892,034 across 2 Biotechnology names. OTLK ranks #2 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
20,943 | $816,986 | |
| 2 | OTLK |
Outlook Therapeutics, Inc.
This page
|
47,200 | $75,048 |
All Filings in OTLK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,048 | 47,200 | Shares | Sole | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||